190 related articles for article (PubMed ID: 38384150)
21. Axial-to-central chirality transfer in cyclization processes.
Campolo D; Gastaldi S; Roussel C; Bertrand MP; Nechab M
Chem Soc Rev; 2013 Nov; 42(21):8434-66. PubMed ID: 23921426
[TBL] [Abstract][Full Text] [Related]
22. Multicomponent reactions (MCR) in medicinal chemistry: a patent review (2010-2020).
Younus HA; Al-Rashida M; Hameed A; Uroos M; Salar U; Rana S; Khan KM
Expert Opin Ther Pat; 2021 Mar; 31(3):267-289. PubMed ID: 33275061
[No Abstract] [Full Text] [Related]
23. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
Patel RN
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
[TBL] [Abstract][Full Text] [Related]
24. Chirality of Central Nervous System (CNS) Acting Drugs: A Formidable Therapeutic Hurdle Against CNS Diseases.
Saganuwan SA
Cent Nerv Syst Agents Med Chem; 2019; 19(3):171-179. PubMed ID: 31232237
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in imine reductase-catalyzed reactions.
Lenz M; Borlinghaus N; Weinmann L; Nestl BM
World J Microbiol Biotechnol; 2017 Oct; 33(11):199. PubMed ID: 29022156
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of chiral building blocks for use in drug discovery.
Marino ST; Stachurska-Buczek D; Huggins DA; Krywult BM; Sheehan CS; Nguyen T; Choi N; Parsons JG; Griffiths PG; James IW; Bray AM; White JM; Boyce RS
Molecules; 2004 May; 9(6):405-26. PubMed ID: 18007441
[TBL] [Abstract][Full Text] [Related]
27. Privileged heterocycles for DNA-encoded library design and hit-to-lead optimization.
Wen X; Wu X; Jin R; Lu X
Eur J Med Chem; 2023 Feb; 248():115079. PubMed ID: 36669370
[TBL] [Abstract][Full Text] [Related]
28. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
Calcaterra A; D'Acquarica I
J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
[TBL] [Abstract][Full Text] [Related]
29. C-H activation reactions as useful tools for medicinal chemists.
Caro-Diaz EJE; Urbano M; Buzard DJ; Jones RM
Bioorg Med Chem Lett; 2016 Nov; 26(22):5378-5383. PubMed ID: 27765505
[TBL] [Abstract][Full Text] [Related]
30. Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.
Khan I; Ibrar A; Zaib S
Top Curr Chem (Cham); 2021 Jan; 379(1):3. PubMed ID: 33398642
[TBL] [Abstract][Full Text] [Related]
31. Chirality and its implications in transdermal drug development.
Reddy IK; Kommuru TR; Zaghloul AA; Khan MA
Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the chemistry and biology of pyridopyrimidines.
Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
[TBL] [Abstract][Full Text] [Related]
33. Anodic Oxidation for the Stereoselective Synthesis of Heterocycles.
Yamamoto K; Kuriyama M; Onomura O
Acc Chem Res; 2020 Jan; 53(1):105-120. PubMed ID: 31872753
[TBL] [Abstract][Full Text] [Related]
34. Recent developments in the combinatorial synthesis of nitrogen heterocycles using solid phase technology.
Chauhan PM; Srivastava SK
Comb Chem High Throughput Screen; 2001 Feb; 4(1):35-51. PubMed ID: 11339216
[TBL] [Abstract][Full Text] [Related]
35. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022.
Rizzo C; Amata S; Pibiri I; Pace A; Buscemi S; Palumbo Piccionello A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175436
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of Polyoxygenated Heterocycles by Diastereoselective Functionalization of a Bio-Based Chiral Aldehyde Exploiting the Passerini Reaction.
Vitali Forconesi G; Banfi L; Basso A; Lambruschini C; Moni L; Riva R
Molecules; 2020 Jul; 25(14):. PubMed ID: 32679733
[TBL] [Abstract][Full Text] [Related]
37. A general method for the enantioselective synthesis of α-chiral heterocycles.
Le PQ; Nguyen TS; May JA
Org Lett; 2012 Dec; 14(23):6104-7. PubMed ID: 23157440
[TBL] [Abstract][Full Text] [Related]
38. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
[TBL] [Abstract][Full Text] [Related]
39. P-chiral phosphorus heterocycles: a straightforward synthesis.
Möller T; Wonneberger P; Kretzschmar N; Hey-Hawkins E
Chem Commun (Camb); 2014 Jun; 50(44):5826-8. PubMed ID: 24675819
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of functionalized tetrasubstituted pyrazolyl heterocycles--a review.
Dadiboyena S; Nefzi A
Eur J Med Chem; 2011 Nov; 46(11):5258-75. PubMed ID: 21978837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
